Aptahem AB

Aptahem operates in the pharmaceutical industry. The company develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's lead candidate is being developed as an emergency drug intended to prevent the onset of life-threatening organ and tissue damage in patients suffering from sepsis. A large part of the research is carried out in collaboration with partners in the industry. The company was founded in 2014 and is headquartered in Malmö.

Quotes for Aptahem AB

Board

CEO

  • Mikael Lindstam

Chairperson of the Board

  • Bert Junno

Board

  • Brian Packard
  • Mikael Lindstam
  • Theresa Comiskey Olsen
Articles of association

Videos

1 / 4
CompanyPresentation Aptahem - Småbolagsdagen Stockholm 12 juni 2023
Interview Intervju med Aptahems VD Mikael Lindstam
Interview Aptahem l Analyst Group intervjuar VD Mikael Lindstam om Q3 2022
Interview 210827 APTAHEM INTERVJU
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-03-31 2025-12-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Number of months that the report spans Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months 2024
Total revenue MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings before interest and tax MSEK -1.39 -6.49 -1.71 -1.39 -1.36 -2.01 -8.20
Profit before tax MSEK -1.39 -6.49 -1.71 -1.39 -1.36 -2.01 -8.57
Net profit MSEK -1.39 -6.49 -1.71 -1.39 -1.36 -2.01 -8.57
Earnings per share SEK -0.07 -0.31 0.02 -0.08 -0.08 -0.17 -0.69
Dividend per share SEK 0,00 0.00 0.00 0,00 0,00 0,00 0.00
Equity MSEK 65.98 67.37 67.37 69.44 65.46 63.44 65.45
Fixed assets MSEK 0.07 0.07 0.07 0.09 0.10 0.10 0.11
Intangible assets MSEK 65.53 65.01 65.01 64.23 64.27 63.48 62.82
Current assets MSEK 1.76 3.40 3.40 6.79 2.50 2.44 4.81
Total asset MSEK 67.40 68.53 68.53 71.17 66.92 66.07 67.79
Long term liabilities MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities MSEK 1.42 1.16 1.16 1.74 1.45 2.63 2.34
Number of shares SEK 20972162.00 20972162.00 20972162.00 17264589.00 17264589.00 12500750.00 12500750.00
*Compiled data from Millistream